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Membrane efﬂux pumpa b s t r a c t
Screening for suppressors of canthin-6-one toxicity in yeast identiﬁed Yap1, a transcription factor
involved in cell response to a broad range of injuries. Although canthin-6-one did not promote a sig-
niﬁcant oxidative stress, overexpression of YAP1 gene clearly increased resistance to this drug. We
demonstrated that Yap1-mediated resistance involves the plasma membrane major-facilitator-
superfamily efﬂux pump Flr1 but not the vacuolar ATP-binding-cassette transporter Ycf1. FLR1 over-
expression was sufﬁcient to reduce sensitivity to the drug, but strictly dependent on a functional
YAP1 gene.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Canthin-6-one alkaloids are naturally produced by plants
belonging to the Simaroubaceae, Zygophyllaceae and Rutaceae
families [1–3]. They exhibit a broad spectrum of antimicrobial [4]
and antifungal activities [3]. Antiparasitic properties have also
been reported [5–7] and decoctions of canthin-6-one producing
plants are used in the treatment of malaria and leishmaniasis in
South America. Traditional medicine also uses these natural prod-
ucts as antipyretic agents and for the treatment of gastric ulcers
and diarrhea [8]. One of these compounds, 1-methoxy-canthin-6-
one, displayed cytotoxic and antiproliferative effects in human cell
cultures [9] and induced apoptosis via a JNK-dependent mecha-
nism [10]. Considering this wide range of biological activities as
well as their very low toxicity on normal cells, these molecules
may represent a potent alternative to current chemotherapies that
display numerous drawbacks. Yet very little is known about the
mechanism of action of these molecules, their cellular targets,
nor the way cells may cope with them to reduce or suppress their
efﬁcacy. A link between the antifungal activity of canthin-6-one
and fatty acid metabolism has been reported [11] in the yeast Sac-
charomyces cerevisiae: upon treatment with a sub-inhibitory con-
centration of the drug, the proportion of unsaturated fatty acidstended to increase, more particularly 9-hexadecenoate (C16 :1),
suggesting that canthin-6-one stimulated desaturase enzyme sys-
tems. This hypothesis was not addressed, however, nor was the
status of the sole alkyl chain fatty acid desaturase of yeast (Ole1)
examined after drug treatment. Consistent with a putative effect
on lipid metabolism, a ﬂuorescent derivative of canthin-6-one
co-localized with cytoplasmic lipid droplets after rapid uptake by
yeast cells [11]. This subcellular localization, if conﬁrmed in human
cells, may be in relation with the analgesic, antipyretic and anti-
inﬂammatory effects of these drugs. Indeed cyclooxygenase-2
(COX-2) and prostaglandin-E2 (PGE2) synthesis involved in the
inﬂammatory response and responsible for the elevated body tem-
perature and fever was shown to reside in lipid bodies of colon
cancer cells [12]. Thus one can speculate that these molecules
when accumulated in lipid droplets may interfere with PGE2 pro-
duction. This hypothesis is not in contradiction with a recent study
showing that anti-ulcer activity of canthin-6-one does not involve
PGE2 synthesis in animal models whereas treatment with this drug
rather resulted in a mild decrease of PGE2 production [8]. Consid-
ering that inhibition of PGE2 synthesis with aspirin signiﬁcantly re-
duced cell proliferation of the CACO-2 colon cancer cell line [12],
this putative effect of canthin-6-one derivatives on PGE2 produc-
tion would certainly deserve to be addressed.
In order to get a better insight into the mechanism of action of
these drugs, we screened a yeast genomic library in S. cerevisiae to
isolate high-copy-number suppressors of canthin-6-one sensitiv-
ity. Among the genes selected with this strategy we isolated the
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various stress, more particularly oxidative stress [13,14], and pleio-
tropic drug resistance in high-copy number [15,16]. More recently,
the involvement of Yap1 in response to genotoxic insults has also
been reported [17]. In this study we showed that plasmid-borne
overexpression of YAP1 leads to canthin-6-one resistance via the
major-facilitator-superfamily (MFS) transporter Flr1 involved in
the efﬂux of a broad range of cytotoxic molecules [15,18,19].
2. Materials and methods
2.1. Yeast strains, culture conditions and plasmids
All S. cerevisiae strains used in this study are listed in Table 1.
Cells were plated on YPD complete medium and strains containing
plasmids were plated on YNB minimal medium supplemented
with appropriate nutrients for maintenance of plasmids and grown
routinely at 28 C. Culture media containing canthin-6-one were
buffered at pH 6 with sodium phosphate. The yeast genomic
DNA library constructed in YEp13 was a kind gift from Dr. Roger
Schneiter (Fribourg University). Plasmids pRS426-Yap1-Myc for
overexpression of YAP1, pRS314-GFP-Yap1 allowing production of
a GFP-tagged Yap1 and pFLR1-K2 for overexpression of FLR1 were
generously provided by Dr. Michel Toledano (Commissariat à
l’Energie Atomique et aux Energies Alternatives, France), Dr. Yoshi-
haru Inoue (Kyoto University) and Dr. Helmut Jungwirth (Graz Uni-
versity) respectively.
2.2. Chemicals
Canthin-6-one was provided by Alpha Chimica (Châtenay-Mal-
abry, France). It was prepared in DMSO at 80 mM and stored at
20 C.
2.3. Measurement of growth inhibition by canthin-6-one
To study the effects of canthin-6-one on growth rate, strains
were pre-grown overnight and then inoculated in fresh medium
to an OD600 nm of 0.2 with canthin-6-one concentration of 20, 40Table 1




MATa his3D1 leu2D0 lys2D0 ura3D WT strain derived from S288c
ybp1D MATa his31 leu2D0 lys20 ura3D0
YBR216C::kanMX4
Deleted in the Yap1-Binding Prote
background
gpx3D MATa his3D1 leu2D0 lys2D0
ura3D0 YIR037W::kanMX4
Deleted in Gpx3 thiol peroxidase.
ycf1D MATa his3D1 leu2D0 lys2D0
ura3D0 YDR135C::kanMX4
Deleted in the vacuolar Yeast Cad
S288c background
ﬂr1D MATa his3D1 leu2D0 lys2D0
ura3D0 YBR008C::kanMX4
Deleted in the plasma membrane
FLuconazole Resistance 1. S288c b
G175-
W303
MATa leu2-3,112 his3-11,15 trp1-1
ura3-1 can1-100
WT strain
YPH250 MATa ade2-101 his3-D200 leu2-D1
lys2-801 trp1-D1 ura3-52
WT strain
yap1D yap1::HIS3 in YPH250 Deleted in the yeast AP-1 like tran










Expression of GFP-tagged YAP1. Derived from pRS314 (CEN6/ARS4, mono
pFLR1-K2 Overexpression of FLR1. Derived from YEp351 (2l origin, multicopy, LE
pHDEL-
RFP
Expression of HDEL-RFP, marker of the nuclear envelop/ER membrane (or 80 lM and DMSO 0.2% in control conditions. Growth rate was
monitored by recording absorbance over time (OD600 nm).
2.4. Spotting assays
For spotting assays, single colonies of S. cerevisiae from plate
cultures were suspended in sterile water, serially diluted (102,
103, 104, 105) and spotted on YPG pH6 containing 10, 20, 30
and 40 lM canthin-6-one or 0.2% DMSO for control conditions
and grown for 5–7 days at 28 C.
2.5. RNA extraction
Three independent cultures of wild-type strain with and with-
out the plasmid for YAP1 overexpression were pre-grown over-
night and then inoculated in fresh medium to an initial OD600 nm
of 0.1. When cultures reached 0.5 OD/ml they were treated for
1 h with 40 lM canthin-6-one or 0.2% DMSO for control condi-
tions. Total RNA extraction was performed as previously described
by Li et al. [20]. Brieﬂy, cells (equivalent to 2.5 OD600 nm units) were
collected by centrifugation and washed in water before suspension
in isolation buffer (10 mM EDTA; 50 mM Tris–HCl; SDS pH 6).
Then, cells were lysed by incubation for 5 min at 65 C. The cell ly-
sate was immediately placed on ice before adding 200 ll 0.3 M KCl.
Supernatant was recovered by centrifugation (12000 rpm for
10 min at 4 C) and total RNA was extracted with phenol/chloro-
form/isoamyl alcohol (25:24:1). RNA precipitation was performed
overnight at 80 C in 3 M sodium acetate pH 5.2 (0.1 vol) and iso-
propanol (2.5 vol). RNA pellet was recovered by centrifugation
(13000 rpm for 20 min at 4 C), washed with 70% cold ethanol,
dried at room temperature and resuspended in DEPC-treated
water. RNA quantiﬁcation was performed by absorbance analysis
at 260 nm and adjusted to 0.25 lg/ll. For cDNA synthesis, 1 lg
of total RNA was used for RT with 50 ng random hexamers (GE
Healthcare Europe, Saclay, France) and Moloney Murine Leukemia
Virus Reverse Transcriptase (M-MLV RT; Promega) for 2 h at 37 C.
The RT reaction was terminated on ice by 1/5 dilution in double-
distilled water.Origin
EUROSCARF (Y10000)
in. S288c EUROSCARF (Y13356)
S288c background EUROSCARF (Y15972)




Gift from Sten Stymne (Swedish University of Agricultural
Sciences)
Gift from Yoshiharu Inoue (Graduate School of Agriculture
Kyoto University)
scription factor Gift from Yoshiharu Inoue
Origin
ulticopy, URA3 Gift from Michel Toledano (Commissariat à l’Energie
Atomique et aux Energies Alternatives, France)
copy, TRP1marker) Gift from Yoshiharu Inoue (Kyoto University)
U2 marker) Gift from Helmut Jungwirth (Graz University)
URA3 marker) Gift from Roger Schneiter (Fribourg University)
Table 2
Primers used for real time qPCR.
Gene Primers qPCR product (bp)
GSH1 (YJL101C) F: TTTGACGCTGACTGTCTTCC 82
R: AGCGGCATTTTTATGATTCC
TRX2 (YGR209C) F: TCCGCTTCTGAATACGACAG 91
R: TCATTTTACATGGCCCACAC
FLR1 (YBR008C) F: CGCTGTTGCTTATGGTTGTT 104
R: CCATATAGGCCAAGCCAACT
YCF1 (YDR135C) F: CACAGACCACCCAAAGAATG 72
R: CGGCCTATAACGAGTGGAAT
YAP1 (YML007W) F: CATATCCGAGTCACCGTTTG 95
R: GATTGGTGTTAGAGGCAGCA
ALG9 (YNL219C) F: CACGGATAGTGGCTTTGGTGAACAATTAC 110
R: TATGATTATCTGGCAGCAGGAAAGAACTTGGG
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The coding regions of the target genes were recovered from
Yeast Genome Database (http://www.yeastgenome.org/). The pri-
mer design was undertaken by the on-line Genscript Primer Design
in advanced mode (http://www.genscript.com/cgi-bin/tools/
primer_genscript.cgi) using the following parameters: size of the
primers between 20 and 25 bases, Tm values of 59 C and amplicon
size between 80 and 110 bp. The primer pairs were veriﬁed withFig. 1. Selection of YAP1 as a suppressor of canthin-6-one inhibition. (A) Sensitivity of
resistant (CR) transformants selected from the library. G175 and CR clones were spotted
compared to the reference strain G175 with or without control plasmid [YEp13] by spotti
YAP1-deleted strain yap1D was compared to the isogenic strain YPH250 in liquid medium
medium with 10–30 lM canthin-6-one. In all cases, the control condition refers to a meBLAST (http://www.blast.org) and by in silico PCR (http://geno-
me.ucsc.edu/cgi-bin/hgPcr) using the genome of S. cerevisiae as a
template. Primers pairs used in this study (listed in Table 2) were
validated as follows: they gave a single PCR product as veriﬁed
by melting curve analysis and agarose gel electrophoresis; the dis-
tribution of PCR sigmoids was linear (r P0.99) over 5 logs of tem-
plate concentration with an efﬁciency of 1.85–1.98. The primers
were provided by Invitrogen™ (Life Technologies, France). Real-
time qPCR was performed on a LightCycler (Roche Applied Sci-G175, transformed with empty plasmid [YEp13], was compared to canthin-6-one
on a medium containing 20 lM canthin-6-one. (B) G175 overexpressing YAP1 was
ng cell suspensions on a medium containing 10–30 lM canthin-6-one. (C) Growth of
with 40 lM canthin-6-one and their sensitivity were tested by spotting them on a
dium containing 0.2% DMSO.
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(Takara-Ozyme, Montigny-le-Bretonneux, France). The ampliﬁca-
tion conditions were: enzyme activation step at 95 C for 30 s fol-
lowed by 45 cycles comprising 10 s at 95 C, 10 s at 60 C, and 10 s
at 72 C. PCR reactions on non-reverse-transcribed RNA samples
from each condition produced no detectable ampliﬁcation, thus
verifying the absence of genomic DNA contamination. ALG9 was
used as reference gene as described by Teste et al. [21]. Reverse
transcripts copy numbers were calculated from standard curves
established with known quantities of each template. Results are
expressed as the ratio of number of copies of the target template
per 105 copies of ALG9 template following 40 lM canthin-6-one
treatments versus 0.2% DMSO (fold increase).
Quantitative data are expressed as mean ± standard error of the
mean (±S.E.M.) of 3 independent experiments. The difference be-
tween groups was analyzed by a paired Student’s t-test and was
considered signiﬁcant when P < 0.05.
3. Results and discussion
3.1. High-copy-number suppression of canthin-6-one sensitivity
A strategy in yeast to isolate cellular targets of a given toxic
molecule consists in overproduction of the target itself or of genesFig. 2. Evaluation of Yap1 dependent oxidative stress response induced by canthin-6-o
observed by confocal microscopy after incubation for 1 h with 200 lM canthin-6-one, 1.
RFP. (B) mRNA level of YAP1 and of Yap1 target genes in the presence of canthin-6-one wa
Stars (H) above bars indicate statistical signiﬁcance of a P-value <0.05. (C) The sensitivit
the presence of 10 mM reduced glutathione (GSH) or 10 mM N-acetyl-cysteine (NAC). (D)
overexpression were spotted on a medium with 10–40 lM canthin-6-one.involved in its production. Indeed the use of a library of wild-type
yeast genomic DNA in a high-copy-number plasmid allows in-
creased gene dosage in order to modify the stoiechiometry be-
tween the target and the toxic molecule thereby reducing its
effect(s). This approach may also lead to the identiﬁcation of an
alternative route(s) to the pathway inhibited by the molecule. A
decrease in drug efﬁciency may also result from an enhanced deg-
radative process, or from the activation of efﬂux pumps, both
mechanisms leading to lower intracellular concentration of the
toxic molecule. Although these two latter processes do not provide
information on the mechanism of action of the drug, their identiﬁ-
cation may be important for future therapeutic development of
this drug. The screening of the library was performed with the
G175 reference strain on a medium containing 20 lM canthin-6-
one. We noticed that growth was more severely affected on solid
medium than in liquid medium (not shown) and that less sensitive
clones appeared at a relatively high frequency (illustrated in
Fig. 1A and B, see G175[Yep13]). G175 was transformed to Leu+
with the library DNA (LEU2 marker, 2 l origin, mean insert size
5–6 kbp) and the transformants (about 25000) growing on
20 lM canthin-6-one were selected. Among a total of nine clones
still signiﬁcantly positive after replica plating (Fig. 1A), partial
sequencing of the inserts allowed us to reduce the number to four
groups. One of them (CR1 for canthin-resistant 1) harbored ane. (A) Yap1-GFP was expressed in a yap1D strain and its cellular localization was
5 mM H2O2 or 0.2% DMSO. Nuclear envelop/ER membrane were labeled with HDEL-
s evaluated by RT-qPCR in the reference strain Y10000. Error bars represent ± S.E.M.
y of reference strains G175, Y10000 and YPH250 to canthin-6-one was evaluated in
Y10000 and mutant strains ybp1D and gpx3Dwith or without the plasmid for YAP1
Fig. 3. Overexpression of YAP1 induced FLR1 and YCF1 expression. Expression of
efﬂux pumps genes FLR1 and YCF1 was studied by RT-qPCR in wild type Y10000
with or without plasmid-borne overexpression of YAP1. Error bars represent± S.E.M.
Stars (H) above bars indicate statistical signiﬁcance of a P-value <0.05.
Fig. 4. Canthin-6-one resistance mediated by YAP1 overexpression is exerted
mainly by Flr1 and not by Ycf1. (A) Sensitivity of strains deleted for FLR1 or YCF1
and overexpressing YAP1 was tested on medium with 30 lM or 40 lM canthin-6-
one. (B) Sensitivity of ﬂr1D was compared to the isogenic strain Y10000 by
recording their growth in liquid medium in the presence of 40 lM canthin-6-one or
in control conditions (0.2% DMSO).
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quences (YAP1 and YML007C-A) and two truncated ones (ERG6,
GIS4). YML007C-A refers to an uncharacterized ORF encoding a
short putative peptide of 36 amino acids with unknown function.
On the other hand, YAP1 encodes the well-characterized yeast
AP1 homologue, a bZIP transcription factor [13] and we estimated
that this gene would be the best candidate to focus on. G175 was
transformed with a high-copy-number plasmid harboring YAP1
and the transformants were plated on canthin-6-one containing
medium. Colonies grew in the presence of canthin-6-one up to
30 lM concentration (Fig. 1B), leading to the conclusion that over-
expression of this transcription factor renders yeast resistant to
this drug.
In order to determine whether YAP1-mediated pathway might
be naturally involved in the cell response to canthin-6-one, we as-
sessed sensitivity to this drug in a YAP1 deleted background. YAP1
inactivation impaired growth under normal conditions (Fig. 1C),
thus we could not ﬁrmly discriminate whether the slight increase
of sensitivity was due to the lack of YAP1 or to growth reduction.
3.2. Canthin-6-one and oxidative stress
The involvement of Yap1 in oxidative stress response has
been extensively studied and documented [13,14]. Yap1 shuttles
between the cytoplasm and the nucleus, and its nuclear locali-
zation is determined by its cysteine-rich domain (CRD) whose
oxidized/reduced status inﬂuences the conformation of the pro-
tein [22]. Ybp1 (Yap1-binding protein) is required for oxidation
of the cysteine residues of Yap1 CRD, and thus is involved in
the nuclear localization of the transcription factor in response
to stress [23]. In this process, Hyr1/Gpx3, a glutathione peroxi-
dase (GPx)-like enzyme, acts as the sensor of intracellular
hydroperoxide levels. In response to peroxide stress, Hyr1/
Gpx3 forms a disulﬁde bond in the CRD of Yap1 with the help
of Ybp1 [24].
The cellular localization of a GFP-tagged version of Yap1 was
assessed after exposure of the yap1D strain to canthin-6-one (1 h
after treatment with 200 lM canthin-6-one). Although a treat-
ment of the cells with H2O2 used as an oxidative stress control
led to a strong and unambiguous nuclear localization, Yap1-
GFP did not accumulate in the nuclear compartment following
canthin-6-one treatment (Fig. 2A). Moreover, it has been re-
ported that YAP1 expression is induced 20 min after exposureto 0.3 mM H2O2 in response to the oxidative stress [25]. Real-
time qPCR was performed with RNA extracted from cells ex-
posed to canthin-6-one (1 h after exposure to 40 lM canthin-6-
one). As shown in Fig. 2B, the transcription level of YAP1 was
not modiﬁed. We also measured by real-time qPCR whether
some of the known Yap1 targets were induced upon canthin-6-
one treatment. GSH1 and TRX2 are known to be induced by
Yap1 in response to oxidative stress [26,27], whereas FLR1 and
YCF1 encode plasma membrane and vacuolar efﬂux pumps
respectively that are involved in the detoxiﬁcation of a wide
variety of xenobiotics [15,18,28–30]. We observed that canthin-
6-one exposure did not induce signiﬁcantly (P > 0.05) GSH1 nor
YCF1. By contrast, FLR1 and TRX2 were signiﬁcantly induced,
but only by a factor of 2.2 and 2.6, respectively, (Fig. 2B). Alto-
gether this data indicate that canthin-6-one does not promote
an oxidative stress comparable to that obtained by H2O2. Despite
this low level of transcriptional activation of FLR1 and TRX2, we
checked the effect of addition of N-acetyl-cysteine or reduced
glutathione (10 mM each) to the culture medium. We observed
a reduction of the sensitivity of the three control strains used
throughout this study (Fig. 2C), suggesting that the redox state
of the cells exposed to canthin-6-one might be affected by the
drug.
Finally we examined whether YAP1 mediated resistance re-
quires Ybp1 and/or Gpx3. As depicted on Fig. 2D, deletion of
any of these genes failed to abolish the effect of YAP1 overex-
pression. Thus plasmid-borne overproduced Yap1 might be suf-
ﬁcient to ensure nuclear accumulation of the transcription
factor thereby rendering the assistance of these factors
unessential.
Fig. 5. Multiple copies of FLR1 induced resistance to canthin-6-one but only in the presence of YAP1. Sensitivity of the reference strains Y10000 and YPH250 and yap1D
overexpressing FLR1 or transformed with the empty plasmid YEp351 was tested by spotting them on a medium containing 10–30 lM canthin-6-one.
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By comparison to the 20-fold increase in FLR1 transcription in
the presence of benomyl [18], this transcript was only moderately
induced upon canthin-6-one exposure (albeit signiﬁcantly). We
thus examined whether this efﬂux pump could play an active role
in Yap1-mediated resistance. Ycf1 is a vacuolar efﬂux pump whose
gene is positively regulated by Yap1 [30]. The transcription level of
FLR1 and YCF1 was examined by real-time qPCR in a strain over-
producing the plasmid-borne Yap1 (Fig. 3). They were both signif-
icantly induced, 11-fold and 1.6-fold, respectively. Although
deletion of YCF1 did not modify the resistance to canthin-6-one
mediated by Yap1, FLR1 inactivation completely abolished this ef-
fect, demonstrating that this drug: H+ antiporter of the plasma
membrane was indeed acting downstream of YAP1 to mediate
resistance to the drug (Fig. 4A). However, we observed that sensi-
tivity to canthin-6-one was not increased in the FLR1-deleted
strain as compared to the control Y10000 (Fig. 4B) showing that
the basal production of this protein is not sufﬁcient to counteract
the effects of canthin-6-one. This observation indicates that this ef-
ﬂux pump is not naturally involved in adaptation of wild-type
yeast to reduce the toxicity of this drug or alternatively that addi-
tional efﬂux pump(s) could be involved in the extrusion of canthin-
6-one.
We then checked the effect of FLR1 overexpression both in a
wild-type background and in a YAP1-deleted background. As de-
picted in Fig. 5, plasmid-borne overproduction of Flr1 led to can-
thin-6-one tolerance, up to 30 lM. This effect was fully
dependent on Yap1 since it was totally abolished in the YAP1-de-
leted strain (Fig. 5). A similar observation was reported by Jung-
wirth et al. [31] in the case of diazaborine resistance mediated
by the Flr1 efﬂux pump, showing that the transcription factor
Yap1 is essential for full activation of FLR1 transcription [19].
3.4. Summary
This study did not provide novel clues about the mechanism of
action of the alkaloid canthin-6-one. Although FLR1 and TRX2, two
well characterized Yap1 target genes, were moderately but signif-
icantly induced upon treatment, our data show that this drug does
not generate a signiﬁcant oxidative stress. However, considering
that addition of N-acetyl-cysteine or reduced glutathione de-
creased sensitivity, the effect of this drug on the redox state of
the cells would deserve further investigation. Given that deletion
of YAP1 resulted in a slight increase of sensitivity, a role of this
transcription factor in the intrinsic resistance to canthin-6-one is
not totally excluded. Additionally we demonstrated that the
MFS-type transporter Flr1 is able to reduce the sensitivity to this
drug when overproduced via a higher gene dosage, and that Flr1-
mediated tolerance to the drug is strictly dependent on the tran-
scription factor Yap1. Thus although the Yap1-Flr1 pair is not nat-
urally involved in yeast tolerance to canthin-6-one, this studydemonstrates that their overexpression can lead to resistance to
the chemical stress generated by this drug.
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